These cells retain their cytotoxic potential and can quickly respond to tumor antigens by producing effector cytokines such as IFN-γ and granzyme B. Depletion of CD103+ TRM cells in murine RCC models leads to accelerated tumor growth, highlighting their vital role in controlling tumor progression. The gene discussed is ITGAE; the disease is neoplasm.